Correlation Between Biotechnology Ultrasector and Strategic Allocation
Can any of the company-specific risk be diversified away by investing in both Biotechnology Ultrasector and Strategic Allocation at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Ultrasector and Strategic Allocation into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotechnology Ultrasector Profund and Strategic Allocation Servative, you can compare the effects of market volatilities on Biotechnology Ultrasector and Strategic Allocation and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Ultrasector with a short position of Strategic Allocation. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Ultrasector and Strategic Allocation.
Diversification Opportunities for Biotechnology Ultrasector and Strategic Allocation
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Biotechnology and Strategic is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Ultrasector Prof and Strategic Allocation Servative in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Strategic Allocation and Biotechnology Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Ultrasector Profund are associated (or correlated) with Strategic Allocation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Strategic Allocation has no effect on the direction of Biotechnology Ultrasector i.e., Biotechnology Ultrasector and Strategic Allocation go up and down completely randomly.
Pair Corralation between Biotechnology Ultrasector and Strategic Allocation
Assuming the 90 days horizon Biotechnology Ultrasector is expected to generate 1.46 times less return on investment than Strategic Allocation. In addition to that, Biotechnology Ultrasector is 6.83 times more volatile than Strategic Allocation Servative. It trades about 0.01 of its total potential returns per unit of risk. Strategic Allocation Servative is currently generating about 0.11 per unit of volatility. If you would invest 526.00 in Strategic Allocation Servative on September 14, 2024 and sell it today you would earn a total of 57.00 from holding Strategic Allocation Servative or generate 10.84% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Biotechnology Ultrasector Prof vs. Strategic Allocation Servative
Performance |
Timeline |
Biotechnology Ultrasector |
Strategic Allocation |
Biotechnology Ultrasector and Strategic Allocation Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Biotechnology Ultrasector and Strategic Allocation
The main advantage of trading using opposite Biotechnology Ultrasector and Strategic Allocation positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Ultrasector position performs unexpectedly, Strategic Allocation can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Strategic Allocation will offset losses from the drop in Strategic Allocation's long position.The idea behind Biotechnology Ultrasector Profund and Strategic Allocation Servative pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Strategic Allocation vs. Mid Cap Value | Strategic Allocation vs. Equity Growth Fund | Strategic Allocation vs. Income Growth Fund | Strategic Allocation vs. Diversified Bond Fund |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |